65,437 trials
Actinic Keratosis
Primary: AE — 3; 0; 2; 3 participants
Binge Eating · Type 2 Diabetes · Food Insecurity
Primary: Recruitment Rate — 30 Participants
Alcohol Use Disorder
Primary: Number of Participants Who Abstained From Alcohol — 13; 9 Participants — p=0.05
Symptomatic Knee Osteoarthritis
Primary: Change From Baseline in Knee Injury and Osteoarthritis Outcome Score (KOOS) Pain Subscale — 21.7; 16.7 score on scale — p=0.0872
Depression
Primary: Change From Baseline in Depression Symptom Burden at 3 Months — 5.6; 7.4 score on a scale — p=<.05
Migraine
Primary: Percentage of Subjects Achieving Headache Pain Freedom at Hour 2 — 43; 22 Participants — p=0.002
Gender Dysphoria
Primary: Receipt of Gender Affirming Treatment — 769; 687; 292; 468 Participants
Suicide Prevention
Primary: Beck Scale for Suicide Ideation (BSS) — 7.8; 7.61; 9.21; 6.78 units on a scale
Alzheimer Disease · Dementia
Primary: Change in Neuropsychiatric Symptoms as Assessed by Neuropsychiatric Inventory (NPI) Score — 3.35; 0.47 score on a scale
Cerebrospinal; Disorder
Primary: Anticipated Drainage of Cerebrospinal Fluid (CSF) — 116 Participants
Distal Radius Fractures
Primary: Safety: Serious Treatment-emergent Adverse Events (TEAEs) and NVDX3-related TEAEs — 1; 1 Participants
Endometriosis · Ovarian Hyperstimulation
Primary: Average Delta in Endometriosis Pain Score Pre and Post Stimulation With and Without Use Of Letrozole — -2.5; -2.7 Change in score on a scale
Basic Science
Primary: Resting-state PMv-M1 Functional Connectivity (Fisher Z-transformed Correlation) — 0.64 unitless (Fisher z-score)
Bipolar Disorder
Primary: Client Satisfaction Questionnaire-8 (CSQ-8) — 27.90 score on a scale
Asthma
Primary: Change From Baseline in Forced Expiratory Volume in 1 Second (FEV1) Area Under the Curve 0 to 3 Hours (AUC0-3) at Week 24 — 0.276; 0.240; 0.067; 0.240 Liter — p=<0.0001